Clinical Trial

Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy

Name: Coenzyme Q10 as Adjunctive Therapy in Drug-Resistant Epilepsy — clinical trial record (NCT07537283)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Q10-DRE

Completed

View on ClinicalTrials.gov →

Summary

This study evaluates the efficacy and safety of coenzyme Q10 supplementation as adjunctive therapy in patients with drug-resistant epilepsy.

Trial Details

NCT Number	NCT07537283
Lead Sponsor	National Cheng-Kung University Hospital
Conditions	Epilepsy, Drugs Resistance
Enrollment	39 participants
Start Date	2023-02-07
Primary Completion	2023-09-28 (estimated)
Study Completion	2023-11-28 (estimated)
Updated on ClinicalTrials.gov	2026-04-17